|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Apte SA, Cavazos DA, Whelan KA and
Degraffenried LA: A low dietary ratio of omega-6 to omega-3 Fatty
acids may delay progression of prostate cancer. Nutr Cancer.
65:556–562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rodriguez C, McCullough ML, Mondul AM,
Jacobs EJ, Chao A, Patel AV, Thun MJ and Calle EE: Meat consumption
among Black and White men and risk of prostate cancer in the cancer
prevention study II nutrition cohort. Cancer Epidemiol Biomarkers
Prev. 15:211–216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walker M, Aronson KJ, King W, Wilson JW,
Fan W, Heaton JP, MacNeily A, Nickel JC and Morales A: Dietary
patterns and risk of prostate cancer in Ontario, Canada. Int J
Cancer. 116:592–598. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hedelin M, Chang ET, Wiklund F, Bellocco
R, Klint A, Adolfsson J, Shahedi K, Xu J, Adami HO, Grönberg H and
Bälter KA: Association of frequent consumption of fatty fish with
prostate cancer risk is modified by COX-2 polymorphism. Int J
Cancer. 120:398–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Norrish AE, Skeaff CM, Arribas GL, Sharpe
SJ and Jackson RT: Prostate cancer risk and consumption of fish
oils: A dietary biomarker-based case-control study. Br J Cancer.
81:1238–1242. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leitzmann MF, Stampfer MJ, Michaud DS,
Augustsson K, Colditz GC, Willett WC and Giovannucci EL: Dietary
intake of n-3 and n-6 fatty acids and the risk of prostate cancer.
Am J Clin Nutr. 80:204–216. 2004.PubMed/NCBI
|
|
9
|
Pham TM, Fujino Y, Kubo T, Ide R, Tokui N,
Mizoue T, Ogimoto I, Matsuda S and Yoshimura T: Fish intake and the
risk of fatal prostate cancer: Findings from a cohort study in
Japan. Public Health Nutr. 12:609–613. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simopoulos AP: The importance of the
omega-6/omega-3 fatty acid ratio in cardiovascular disease and
other chronic diseases. Exp Biol Med (Maywood). 233:674–688. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Lorgeril M and Salen P: New insights
into the health effects of dietary saturated and omega-6 and
omega-3 polyunsaturated fatty acids. BMC Med. 10:502012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berquin IM, Edwards IJ and Chen YQ:
Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer
Lett. 269:363–377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Patel MI, Kurek C and Dong Q: The
arachidonic acid pathway and its role in prostate cancer
development and progression. J Urol. 179:1668–1675. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hajjaji N and Bougnoux P: Selective
sensitization of tumors to chemotherapy by marine-derived lipids: A
review. Cancer Treat Rev. 39:473–488. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Larsson SC, Kumlin M, Ingelman-Sundberg M
and Wolk A: Dietary long-chain n-3 fatty acids for the prevention
of cancer: A review of potential mechanisms. Am J Clin Nutr.
79:935–945. 2004.PubMed/NCBI
|
|
16
|
Azrad M, Turgeon C and Demark-Wahnefried
W: Current evidence linking polyunsaturated Fatty acids with cancer
risk and progression. Front Oncol. 3:2242013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fradet V, Cheng I, Casey G and Witte JS:
Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation,
and aggressive prostate cancer risk. Clin Cancer Res. 15:2559–2566.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pelser C, Mondul AM, Hollenbeck AR and
Park Y: Dietary fat, fatty acids, and risk of prostate cancer in
the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers
Prev. 22:697–707. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McEntee MF, Ziegler C, Reel D, Tomer K,
Shoieb A, Ray M, Li X, Neilsen N, Lih FB, O'Rourke D and Whelan J:
Dietary n-3 polyunsaturated fatty acids enhance hormone ablation
therapy in androgen-dependent prostate cancer. Am J Pathol.
173:229–241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Berquin IM, Min Y, Wu R, Wu J, Perry D,
Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, et al:
Modulation of prostate cancer genetic risk by omega-3 and omega-6
fatty acids. J Clin Invest. 117:1866–1875. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pereira SL, Huang YS, Bobik EG, Kinney AJ,
Stecca KL, Packer JC and Mukerji P: A novel omega3-fatty acid
desaturase involved in the biosynthesis of eicosapentaenoic acid.
Biochem J. 378:665–671. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Zhang M and Gou K: SDD17
desaturase can convert arachidonic acid to eicosapentaenoic acid in
mammalian cells. Biochem Biophys Res Commun. 394:158–162. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Z, Zhang Y, Jia C, Wang Y, Lai P,
Zhou X, Song Q, Lin J, Ren Z, Gao Q, et al: mTORC1/2 targeted by
n-3 polyunsaturated fatty acids in the prevention of mammary
tumorigenesis and tumor progression. Oncogene. 33:4548–4557. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan J, Cheng L, Bi X, Zhang X, Liu S, Bai
X, Li F and Zhao AZ: Elevation of ω-3 polyunsaturated fatty acids
attenuates PTEN-deficiency induced endometrial cancer development
through regulation of COX-2 and PGE2 Production. Sci Rep.
5:149582015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng H, Tang H, Liu M, He M, Lai P, Dong
H, Lin J, Jia C, Zhong M, Dai Y, et al: Inhibition of endometrial
cancer by n-3 polyunsaturated fatty acids in preclinical models.
Cancer Prev Res (Phila). 7:824–834. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gago-Dominguez M, Yuan JM, Sun CL, Lee HP
and Yu MC: Opposing effects of dietary n-3 and n-6 fatty acids on
mammary carcinogenesis: The Singapore Chinese Health Study. Br J
Cancer. 89:1686–1692. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arem H, Neuhouser ML, Irwin ML, Cartmel B,
Lu L, Risch H, Mayne ST and Yu H: Omega-3 and omega-6 fatty acid
intakes and endometrial cancer risk in a population-based
case-control study. Eur J Nutr. 52:1251–1260. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen HZ, Tsai SY and Leone G: Emerging
roles of E2Fs in cancer: An exit from cell cycle control. Nat Rev
Cancer. 9:785–797. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu M, Seto E and Zhang J: E2F1 enhances
glycolysis through suppressing Sirt6 transcription in cancer cells.
Oncotarget. 6:11252–11263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maudet C, Mano M, Sunkavalli U, Sharan M,
Giacca M, Förstner KU and Eulalio A: Functional high-throughput
screening identifies the miR-15 microRNA family as cellular
restriction factors for Salmonella infection. Nat Commun.
5:47182014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jaganathan A, Chaurasia P, Xiao GQ,
Philizaire M, Lv X, Yao S, Burnstein KL, Liu DP, Levine AC and
Mujtaba S: Coactivator MYST1 regulates nuclear factor-κB and
androgen receptor functions during proliferation of prostate cancer
cells. Mol Endocrinol. 28:872–885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang S, Li W, Xue Z, Lu Y, Narsinh K, Fan
W, Li X, Bu Q, Wang F, Liang J, et al: Molecular imaging of p53
signal pathway in lung cancer cell cycle arrest induced by
cisplatin. Mol Carcinog. 52:900–907. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee KY, Lee JW, Nam HJ, Shim JH, Song Y
and Kang KW: PI3-kinase/p38 kinase-dependent E2F1 activation is
critical for Pin1 induction in tamoxifen-resistant breast cancer
cells. Mol Cells. 32:107–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gomez-Gutierrez JG, Garcia-Garcia A, Hao
H, Rao XM, de Montes Oca-Luna R, Zhou HS and McMasters KM:
Adenovirus-mediated expression of truncated E2F-1 suppresses tumor
growth in vitro and in vivo. Cancer. 116:4420–4423. 2010.
View Article : Google Scholar : PubMed/NCBI
|
